Literature DB >> 28072910

Crosstalk between intestinal epithelial cell and adaptive immune cell in intestinal mucosal immunity.

Jun Tao Lu1, An Tao Xu1, Jun Shen1, Zhi Hua Ran1.   

Abstract

Constantly challenged by luminal bacteria, intestinal epithelium forms both a physical and biochemical defense against pathogens. Besides, intestinal epithelium senses dynamic and continuous changes in luminal environment and transmits signals to subjacent immune cells accordingly. It has been long accepted that adaptive immune cells fulfill their roles partly by modulating function of intestinal epithelial cells. Recent studies have brought up the proposal that intestinal epithelial cells also actively participate in the regulation of adaptive immunity, especially CD4+ adaptive T cells, which indicates that there is reciprocal crosstalk between intestinal epithelial cells and adaptive immune cells, and the crosstalk may play important role in intestinal mucosal immunity. This Review makes a comprehensive summary about crosstalk between intestinal epithelial cells and CD4+ adaptive T cells in intestinal immunity. Special attention would be given to their implications in inflammatory bowel disease pathogenesis and potential therapeutic targets.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  CD4+ adaptive T cells; IBD; crosstalk; intestinal epithelial cells; intestinal mucosal immunity

Mesh:

Year:  2017        PMID: 28072910     DOI: 10.1111/jgh.13723

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  T-cell immune response against cytomegalovirus in peripheral blood and colonic mucosa from ulcerative colitis and Crohn's disease patients.

Authors:  Seung-Joo Nam; Eun Sun Kim; Yoon Tae Jeen
Journal:  Intest Res       Date:  2018-01-18

Review 2.  Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies.

Authors:  Tian Tian; Ziling Wang; Jinhua Zhang
Journal:  Oxid Med Cell Longev       Date:  2017-06-28       Impact factor: 6.543

Review 3.  The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.

Authors:  Grainne Holleran; Loris Lopetuso; Valentina Petito; Cristina Graziani; Gianluca Ianiro; Deirdre McNamara; Antonio Gasbarrini; Franco Scaldaferri
Journal:  Int J Mol Sci       Date:  2017-09-21       Impact factor: 5.923

Review 4.  Gut integrity in critical illness.

Authors:  Shunsuke Otani; Craig M Coopersmith
Journal:  J Intensive Care       Date:  2019-03-20

Review 5.  Protease-Activated Receptors - Key Regulators of Inflammatory Bowel Diseases Progression.

Authors:  Damian Jacenik; Jakub Fichna; Ewa Małecka-Wojciesko; Anna Mokrowiecka
Journal:  J Inflamm Res       Date:  2021-12-29

6.  Effects of Shrimp Peptide Hydrolysate on Intestinal Microbiota Restoration and Immune Modulation in Cyclophosphamide-Treated Mice.

Authors:  Asif Iqbal Khan; Ata Ur Rehman; Nabeel Ahmed Farooqui; Nimra Zafar Siddiqui; Qamar Ayub; Muhammad Noman Ramzan; Liang Wang; Yi Xin
Journal:  Molecules       Date:  2022-03-06       Impact factor: 4.411

7.  Effect of crude polysaccharide from seaweed, Dictyopteris divaricata (CDDP) on gut microbiota restoration and anti-diabetic activity in streptozotocin (STZ)-induced T1DM mice.

Authors:  Nimra Zafar Siddiqui; Ata Ur Rehman; Waleed Yousuf; Asif Iqbal Khan; Nabeel Ahmed Farooqui; Shizhu Zang; Yi Xin; Liang Wang
Journal:  Gut Pathog       Date:  2022-09-17       Impact factor: 5.324

8.  Class A1 scavenger receptors mediated macrophages in impaired intestinal barrier of inflammatory bowel disease.

Authors:  Chenxi Xie; Yanyun Fan; Yinshi Huang; Shuangting Wu; Haimei Xu; Lupeng Liu; Yiqun Hu; Qingwen Huang; Huaxiu Shi; Lin Wang; Hongzhi Xu; Jingling Su; Jianlin Ren
Journal:  Ann Transl Med       Date:  2020-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.